References
- Al Husaini H, Wheatley-Price P, Clemons M, Shepherd FA (2009). Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol, 4, 251-9. https://doi.org/10.1097/JTO.0b013e31819518fc
- Brown JE, Cook RJ, Major P, et al. (2005). Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst, 97, 59-69. https://doi.org/10.1093/jnci/dji002
- Carney DN (2002). Lung cancer-time to move on from chemotherapy. N Engl J Med, 346, 126-8. https://doi.org/10.1056/NEJM200201103460211
- Chute JP, Chen T, Feigal E, et al. (1999). Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol, 17, 1794-801.
- Cristofanilli M (2014). Circulating tumour cells: telling the truth about metastasis. Lancet Oncol, 15, 365-6. https://doi.org/10.1016/S1470-2045(14)70091-9
- Cristofanilli M, Budd GT, Ellis MJ, et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 351, 781-91. https://doi.org/10.1056/NEJMoa040766
- Currie GP, Kennedy AM, Denison AR (2009). Tools used in the diagnosis and staging of lung cancer: what's old and what's new? QJM, 102, 443-8. https://doi.org/10.1093/qjmed/hcp038
- Fidler IJ (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res, 38, 2651-60.
- Goldstraw P, Crowley J, Chansky K, et al (2007). The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2, 706-14. https://doi.org/10.1097/JTO.0b013e31812f3c1a
- Gorges TM, Tinhofer I, Drosch M, et al (2012). Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer, 12, 178. https://doi.org/10.1186/1471-2407-12-178
- Gregory DL, Hicks RJ, Hogg A, et al (2012). Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data. J Nucl Med, 53, 1007-15. https://doi.org/10.2967/jnumed.111.099713
- Grover PK, Cummins AG, Price TJ, et al (2014). Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol, 25, 1506-16 https://doi.org/10.1093/annonc/mdu018
- Hamilton W, Sharp D (2004). Diagnosis of lung cancer in primary care: a structured review. Fam Pract, 21, 605-11. https://doi.org/10.1093/fampra/cmh605
- Herbst RS, Heymach JV, Lippman SM (2008). Lung cancer. N Engl J Med, 359, 1367-80. https://doi.org/10.1056/NEJMra0802714
- Hiltermann TJ, Pore MM, van den Berg A, et al (2012). Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol, 23, 2937-42. https://doi.org/10.1093/annonc/mds138
- Hou JM, Krebs M, Ward T, et al (2011). Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol, 178, 989-96. https://doi.org/10.1016/j.ajpath.2010.12.003
- Isobe K, Hata Y, Kobayashi K, et al (2012). Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer. Anticancer Res, 32, 3339-44.
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Krebs MG, Hou JM, Ward TH, et al (2010). Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol, 2, 351-65. https://doi.org/10.1177/1758834010378414
- Lee JW, Lee SM, Lee HS, et al (2012). Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer. Ann Nucl Med, 26, 627-33. https://doi.org/10.1007/s12149-012-0622-3
- Ma XL, Xiao ZL, Liu L, et al (2012). Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev, 13, 1137-44. https://doi.org/10.7314/APJCP.2012.13.4.1137
- Mego M, De Giorgi U, Broglio K, et al (2009). Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. Br J Cancer, 101, 1813-6. https://doi.org/10.1038/sj.bjc.6605413
- Mulshine JL, Smith RA (2002). Lung cancer. 2: screening and early diagnosis of lung cancer. Thorax, 57, 1071-8. https://doi.org/10.1136/thorax.57.12.1071
- Ni X, Zhuo M, Su Z, et al. (2013). Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA, 110, 21083-8. https://doi.org/10.1073/pnas.1320659110
- O'Flaherty JD, Gray S, Richard D, et al (2012). Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer, 76, 19-25. https://doi.org/10.1016/j.lungcan.2011.10.018
- Pierga JY, Bidard FC, Cropet C, et al (2013). Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial. Ann Oncol, 24, 2999-3004. https://doi.org/10.1093/annonc/mdt348
- Portilla-Quattrociocchi H, Banzo I, Martinez-Rodriguez I, et al. (2011). (Evaluation of bone scintigraphy and (18) F-FDG PET/CT in bone metastases of lung cancer patients). Rev Esp Med Nucl, 30, 2-7. https://doi.org/10.1016/j.remn.2010.10.005
- Riethdorf S, Wikman H, Pantel K (2008). Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer, 123, 1991-2006. https://doi.org/10.1002/ijc.23825
- Schmidt GP, Reiser MF, Baur-Melnyk A (2009). Wholebody MRI for the staging and follow-up of patients with metastasis. Eur J Radiol, 70, 393-400. https://doi.org/10.1016/j.ejrad.2009.03.045
- Shapley M, Mansell G, Jordan JL, Jordan KP (2010). Positive predictive values of >/=5% in primary care for cancer: systematic review. Br J Gen Pract, 60, 366-77. https://doi.org/10.3399/bjgp10X515412
- Shiota M, Bishop JL, Nip KM, et al (2013). Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Res, 73, 3109-19.
- Sone S, Yano S (2007). Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev, 26, 685-9. https://doi.org/10.1007/s10555-007-9081-z
- Stenbygaard LE, Sorensen JB, Larsen H, Dombernowsky P (1999). Metastatic pattern in non-resectable non-small cell lung cancer. Acta Oncol, 38, 993-8. https://doi.org/10.1080/028418699432248
- Stovold R, Blackhall F, Meredith S, et al (2012). Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells. Lung Cancer-J Iaslc, 76, 263-8. https://doi.org/10.1016/j.lungcan.2011.11.015
- Tarhan MO, Gonel A, Kucukzeybek Y, et al (2013). Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev, 14, 1725-9. https://doi.org/10.7314/APJCP.2013.14.3.1725
- Tseng JY, Yang CY, Liang SC, et al (2014). Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases. Clin Cancer Res, 20, 2885-97. https://doi.org/10.1158/1078-0432.CCR-13-2162
- Turker I, Uyeturk U, Sonmez OU, et al (2013). Detection of circulating tumor cells in breast cancer patients: prognostic predictive role. Asian Pac J Cancer Prev, 14, 1601-7. https://doi.org/10.7314/APJCP.2013.14.3.1601
- Wang FB, Yang XQ, Yang S, et al (2011). A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients-a meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
- Wang Y, van Klaveren RJ, van der Zaag-Loonen HJ, et al (2008). Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology, 248, 625-31. https://doi.org/10.1148/radiol.2482070957
- Wong MP (2012). Circulating tumor cells as lung cancer biomarkers. J Thorac Dis, 4, 631-4.
Cited by
- Steroidal Saponins from Paris polyphylla Suppress Adhesion, Migration and Invasion of Human Lung Cancer A549 Cells Via Down-Regulating MMP-2 and MMP-9 vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10911
- Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy vol.6, pp.1, 2016, https://doi.org/10.1038/srep31423
- Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3471-6
- Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip vol.18, pp.2, 2018, https://doi.org/10.1007/s10238-018-0485-6
- Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours vol.120, pp.3, 2019, https://doi.org/10.1038/s41416-018-0367-4
- Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo vol.19, pp.1, 2019, https://doi.org/10.1186/s12935-019-0735-z